Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and Rituximab and hyaluronidase human, recombinant Subcutaneous
Determining the interaction of Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and Rituximab and hyaluronidase human, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Hyaluronidase and rituximab, Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Rituximab Intravenous
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Riva-Amoxicillin
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Rivaroxaban
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Rivastigmine
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Rivastigmine Capsules
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Rivastigmine Oral Solution
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Kitabis Pak
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Kitabis Pak inhalation
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Klofensaid II
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Klonopin
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Klonopin Wafer